Acorda Therapeutics Inc (ACOR)

NASDAQ
0.468
+0.007(+1.52%)
After Hours
0.468
0.000(0.00%)
- Real-time Data
  • Volume:
    96,809
  • Day's Range:
    0.450 - 0.480
  • 52 wk Range:
    0.276 - 4.990

ACOR Overview

Prev. Close
0.461
Day's Range
0.45-0.48
Revenue
122.01M
Open
0.461
52 wk Range
0.276-4.99
EPS
-8.96
Volume
96,809
Market Cap
11.36M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,800,738
P/E Ratio
-0.052
Beta
0.467
1-Year Change
-86.93%
Shares Outstanding
24,272,140
Next Earnings Date
Nov 08, 2022
What is your sentiment on Acorda?
or
Market is currently closed. Voting is open during market hours.

Acorda Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Acorda Therapeutics Inc Analysis

Acorda Therapeutics Inc Company Profile

Acorda Therapeutics Inc Company Profile

Employees
118

Acorda Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing therapies that restore function and enhance the lives of people with neurological disorders. The Company uses its ARCUS pulmonary delivery system, which is a technology platform designed to deliver medication through inhalation that is used in the development of a variety of inhaled medicines. The Company’s products include INBRIJA (levodopa inhalation powder) and AMPYRA (dalfampridine). INBRIJA is an inhaled levodopa (L-dopa) for intermittent treatment of OFF episodes, also known as OFF periods in people with Parkinson’s disease treated with carbidopa/levodopa regimen. INBRIJA utilizes its ARCUS platform for inhaled therapeutics. AMPYRA (dalfampridine) is an extended-release tablet formulation of dalfampridine as a treatment to enhance walking in patients with multiple sclerosis (MS). Ampyra is marketed as Fampyra outside the United States by Biogen International GmbH.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyBuyBuyStrong Sell
Technical IndicatorsBuyNeutralStrong BuyBuyStrong Sell
SummaryBuyBuyStrong BuyBuyStrong Sell
  • RS
    2
    • EPS > 0 ?!
      1
      • It will be up!
        1
        • Mr Cohen what do you make with money of the investors
          0
          • Israeli CEO what you expect, look at the stock price since 3 years - trash
            1
            • Nice targets, after 2 years maybe...
              0
              • Entered with 12.000€ at 4.82. Target price 5.90 in 3 days at most.
                1
                • NicolaWISH you good luckAcora targe price change from 5 to $10
                  0
              • Soon will be 14$
                1
                • Never
                  0
              • Did you guys noticed that?
                0
                • Hi guys is anyone of you aware that this company had a consolidation on the 4th of January, where you were given 1share for every 6 shares, for example if you had 12 shares before the 4th, you now have 2. And the price also went up from 75cents to 3.75 dollars...
                  0